CClinicalTrials.gg
CompletedNCT05599503Updated Mar 19, 2024

SimpleC Wellness Platform With Social Robot Interaction (Long-term)

An interventional study of Behavioral Interventions and Robot Interventions in Engagement, Patient, Quality of Life and Mood, sponsored by SimpleC, LLC. Completed at 2 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-03-19.

Sponsored by SimpleC, LLC · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
63
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study will be conducted to test a Socially-Assistive Robot (SAR) system for residents in an Assisted Living environment. The goal of the SAR system is to enhance social engagement and connectedness. The system engages residents via robot-facilitated activities such as trivia and reminder and is integrated with the SimpleC Wellness Platform.

Read the detailed description

This is a mixed-method study to assess the effectiveness of the SAR system. The study includes behavior/lifestyle intervention that are delivered via a robot and/or tablet. The study intervention is a Social Assistive Robot (SAR) System. The SAR system contains the SimpleC Platform, physical robot, virtual agent/robot.

The goal is to engage residents in a natural language conversation as psychosocial support (enhancing mood, mitigating the effects of loneliness, and enhancing social connection and communication) and provide value to the organization and its staff.

Research questions include:

  1. Are existing and new residents engaged and satisfied with the Technology Intervention Program?
  2. What are the benefits (health, behavioral, economic, and social) of the virtual agent and physical robot?
  3. Which users will adopt the SAR system?
  4. What are facilitators and barriers to SAR system adoption?
  5. Does Technology Acceptance Theory explain adoption over time?
  6. Do changing needs affect changing technology attitude?
  7. What are guidelines for implementation and design?

Sample: 270 individuals will participate: 90 residents, 90 family, and 90 staff across different study locations. Enrollment will be stopped upon reaching saturation.

  1. Participants in both conditions will have access to personal media, reminders, televisit, messaging, news, and wellness programs in their own room via the Companion.
  2. Participants in the SAR condition will have access to social and health reminders as well as social and wellness programs facilitated by a virtual robot agent in their own room via the Companion.
  3. Participants in the SAR condition will also have access to social and health reminders as well as social and wellness programs facilitated by a physical robot in the community area and a staff member (likely the activity director).

The goal is to offer SAR-facilitated group session at least once per week, for residents to attend at least one such session over the course of the study and two sessions/month.

02

Conditions studied

  • Engagement, Patient
  • Quality of Life
  • Mood
  • Aging Well
  • Cognitive Change
  • Mild Cognitive Impairment
  • Cognitive Impairment
  • Dementia

Keywords

  • At risk, diagnosis
03

In context

Dementia

2,172 studies on the registry are indexed under Dementia; 540 are open to participants now.

This study's enrollment of 63 is below the median of 83 across 1,629 interventional studies indexed under Dementia.

Browse Dementia studies →

Lead sponsor

SimpleC, LLC is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Resident Inclusion Criteria:

  • Aged 50+ years
  • Any gender
  • Fluent in English
  • New or current user of SimpleC
  • At risk for MCI; MCI; moderate / cognitive impairment (MMSE score of 13 or higher)

Family Member Inclusion Criteria:

  • Aged 18+ years
  • Any gender
  • Fluent in English
  • Family or friend of resident
  • New or current user of SimpleC
  • No diagnosis of dementia or related disorder

Staff Inclusion Criteria:

  • Aged 18+ years
  • Any gender
  • Fluent in English
  • Works for the Senior Housing Community
  • New or current user of SimpleC

Resident Exclusion Criteria:

  • Comorbidities or psychiatric history that would preclude study participation
  • Expecting to move during the study (i.e., move out of facility)
  • Both legally deaf and blind
  • Not able to press tablet buttons
  • Not able to verbally answer questionnaires
  • Pregnant

Family Caregiver Exclusion Criteria:

  • Comorbidities or psychiatric history that would preclude study participation
  • Expecting to move during the study (i.e., move out of facility)
  • Both legally deaf and blind
  • Not able to press tablet buttons
  • Pregnant

Staff Exclusion Criteria:

  • Expecting to move during the study (i.e., move out of facility)
  • Both legally deaf and blind
  • Pregnant
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
63 participants (actual)

Study arms

  • Experimental
    SimpleC Wellness Platform with Social Robot Interaction

    Participants in the Social Robot condition will have access to personal media, reminders, televisit, messaging, news, and wellness programs in their own room via the Companion. Participants will also will have access to social and health reminders as well as social and wellness programs facilitated by a virtual robot agent in their own room via the Companion, social and health reminders as well as social and wellness programs facilitated by a physical robot in the community area and a staff member (likely the activity director).

    Behavioral: Behavioral Interventions · Behavioral: Robot Interventions

  • Active comparator
    SimpleC Wellness Platform

    Participants in the SimpleC Wellness Platform condition will have access to personal media, reminders, televisit, messaging, news, and wellness programs in their own room via the Companion.

    Behavioral: Behavioral Interventions

Interventions

  • BehavioralBehavioral Interventions

    Traditional SimpleC Wellness

  • BehavioralRobot Interventions

    Robot interventions

06

What researchers measure

Primary outcomes

  1. Change in Robotic Social Attributes Scale (RoSAS). An 18-item scale with high scores indicating positive attitudes for dimensions of warmth and competency and a negative attitude for dimension of discomfort.

    \[Questionnaire\] Perception and judgment of Social Assistive Robot social attributes on 3 dimensions: Warmth, competency, and discomfort

    Time frame: Midpoint (3 months), Final (6 months)

  2. Change in Caregiver Guilt Scale. A 4-point scale with higher score indicating higher guilt.

    \[Questionnaire\] Family caregiver feelings of guilt.

    Time frame: Baseline, Midpoint (3 months), Final (6 months)

  3. Change in Perceived Stress Scale. A 5-point scale with higher scores indicating higher stress.

    \[Questionnaire\] Family caregiver experience of stress in the past 4 months. Modification: Answer as it relates to caregiving.

    Time frame: Baseline, Midpoint (3 months), Final (6 months)

  4. Change in Technology Acceptance and Experience Questionnaire. A scale with high scores indicating higher acceptance.

    \[Questionnaire\] Assessment of users' perceived ease of use, usefulness, and satisfaction of using the technology.

    Time frame: Midpoint (3 months), Final (6 months)

  5. Change in Quality of Life. A 13-item survey with high scores indicating higher quality of life.

    \[Questionnaire\] Assessment of different aspects of quality of life, including physical health, energy, family, money.

    Time frame: Baseline, Midpoint (3 months), Final (6 months)

Secondary outcomes

  1. Technology acceptance and adoption Interview.

    \[Interview\] Assessment of users acceptance and adoption ease of use, usefulness, and satisfaction of using the technology.

    Time frame: Midpoint (3 months)

  2. Technology acceptance and adoption Interview.

    \[Interview\] Assessment of users acceptance and adoption ease of use, usefulness, and satisfaction of using the technology.

    Time frame: Final (6 months)

  3. Usability and usefulness

    Identified factors that indicate the ease of use and usefulness for different tasks as derived from analysis of: \[Interview, usage data\]

    Time frame: 6 months

  4. Conversation quality

    \[Interview\] User perceptions on the usefulness and ease of use in conversing with the technology.

    Time frame: 6 months

  5. Value proposition/Economic Impact

    \[Interview\] Discussions with facility staff and key decision makers to understand the value of the technology in providing social interaction and reminders to their residents.

    Time frame: 6 months

  6. Requirements

    Identified requirements for design, training, and communication as derived from analysis of: \[Interview, observations\]

    Time frame: 6 months

  7. Affect

    \[Interview\] Feelings of enjoyment, satisfaction, when using the technology

    Time frame: 6 months

  8. Participation Pattern

    How often system is used, buttons clicked, voice activation \[usage data, interview, observations\]

    Time frame: 6 months

07

Study locations

2 sites
  • University of Georgia
    Athens, Georgia 30602, United States
  • SimpleC
    Atlanta, Georgia 30060, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05599503
Lead sponsor
SimpleC, LLC
Collaborators
University of Georgia, Advanced Medical Electronics
Responsible party
Sponsor
First posted
Oct 31, 2022
Start date
Aug 10, 2022
Primary completion
Nov 13, 2023
Completion
Nov 13, 2023
Last update
Mar 19, 2024

Study contacts

Anne Adams, PhD
principal investigator · SimpleC, LLC
Jenay M Beer, PhD
principal investigator · University of Georgia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion